To better understand the impact of Kras imbalance in vivo, we assessed the impact of Kras LOH upon both the development of benign pancreatic precursor lesions, known as PanIN, and ultimately the development of pancreatic cancer. This evidence concerns the gene KRAS and familial pancreatic carcinoma.